Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2020-04-09 2020-02-21
Drug Identification Number 02143305 02143305
Brand name VINCRISTINE SULFATE INJECTION VINCRISTINE SULFATE INJECTION
Common or Proper name VINCRISTINE INJECTION 1MG/ML VINCRISTINE INJECTION 1MG/ML
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients VINCRISTINE SULFATE VINCRISTINE SULFATE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1ml 1ml
ATC code L01CA L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-20 2020-02-20
Estimated end date 2020-04-30 2020-03-31
Actual end date 2020-04-08
Shortage status Resolved Actual shortage
Company comments
Health Canada comments